Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism.
about
Immunotherapy as treatment for Alzheimer’s diseaseConcomitant pathologies among a spectrum of parkinsonian disordersAltered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial DopplerCerebrovascular reactivity to carbon dioxide in Alzheimer's disease.Comparing Cerebral White Matter Lesion Burdens between Parkinson's Disease with and without Dementia.Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 miceGenetics of Vascular Dementia.Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.Prevalence of dementia subtypes in a developing country: a clinicopathological study.Plasma Total Homocysteine Levels are not Associated with Medial Temporal Lobe Atrophy, but with White Matter Changes in Alzheimer's DiseaseCognitive impairment risk: white matter hyperintensity progression matters.Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample.Association of cardiovascular system medications with cognitive function and dementia in older adults living in nursing homes in Australia.Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage.Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).Vascular dementia: Diagnostic criteria and supplementary exams. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part I.Prospective motion correction enables highest resolution time-of-flight angiography at 7T.The cerebrovascular pathology in Alzheimer's disease and its influence on clinical variables.Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics.
P2860
Q22241491-FFCDA825-FB5F-466C-BA8C-BB546E2836FCQ28236077-18A08DD0-423C-4FA2-A0DF-A043CE134497Q30473135-7770E1D1-53A1-49D2-99BD-0C19DAAF382AQ30597321-167D7C59-4E75-4281-8BEB-D4059F1A0BABQ33636257-F731331A-61B1-42B9-9436-70311A671959Q34889214-0FECD59B-6089-4D4D-85AD-511D659E9E7FQ35094704-7B368430-3274-4A06-8721-2AA25830B64CQ37109969-CC06B41F-6701-41C6-94E5-E65E8BF6808AQ37119098-F53619BE-C082-44C3-9373-C1E234937E5EQ37252149-F237429D-D3BC-4F77-9A2D-F6E384030345Q37268286-8F5B4FC6-E559-4D40-8672-950FE6CD26B1Q38259551-8A1B6B02-60E3-432F-ACE3-EAD1A5F0AFD7Q40464051-7EA2AEB7-F8A5-4E72-BD71-438B94D96520Q42875420-0384DD50-5CCC-4D6B-8EF9-C02805B69C4BQ43586668-EAB9F60C-2263-440D-86BE-901C39A37FD9Q46727035-0FC33C9F-EA3D-4DE5-8C59-8B526A5698E3Q47137433-591EF427-4F4F-4F05-874C-088FD4943261Q47259149-6D8BD558-30DF-41AA-BA4C-84136FC2733CQ51893815-94B12F30-B62E-4B8D-9F6F-3709CA09ADB9Q55252662-D52ACEB7-39BB-4F88-9582-6040C96E237EQ55257582-09156EE2-D99F-4453-AE96-7A93DECD44B7
P2860
Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Prevalence and impact of cereb ...... er's disease and parkinsonism.
@en
Prevalence and impact of cereb ...... er's disease and parkinsonism.
@nl
type
label
Prevalence and impact of cereb ...... er's disease and parkinsonism.
@en
Prevalence and impact of cereb ...... er's disease and parkinsonism.
@nl
prefLabel
Prevalence and impact of cereb ...... er's disease and parkinsonism.
@en
Prevalence and impact of cereb ...... er's disease and parkinsonism.
@nl
P2860
P921
P1476
Prevalence and impact of cereb ...... er's disease and parkinsonism.
@en
P2093
Jellinger KA
P2860
P356
10.1111/J.1600-0404.2006.00665.X
P407
P577
2006-07-01T00:00:00Z